Nr 546 final exam 2024 - Study guides, Class notes & Summaries

Final Exam: NR546/ NR 546 Psychopharmacology for the Psychiatric- Mental Health Nurse Practitioner Final Exam | Graded A Questions and Verified Answers| Latest Update 2023/ 2024 |Chamberlain QUESTION The treatment efficacy of selective serotonin reuptake inhibitors (SSRIs), the most used first -line pharmacological agent is between ______________ with reported remission rates as low as ______ Answer: 48 and 64%, 23.5% QUESTION Is ...

Midterm Exam: NR546/ NR 546 Psychopharmacology for the Psychiatric Mental Health Nurse Practitioner| 2023/ 2024 Update| Latest!!! Questions and Verified Answers| Chamberlain QUESTION Damage to the anterior portion may cause astrogenesis, the loss of ability to recognize objects via the sense of touch. This may be experienced by patients with post cerebral vascular accidents Answer: parietal Lobe QUESTION and involved in short-term memory, speech, auditory signals, and ...

Final Exam: NR546/ NR 546 Psychopharmacology for the Psychiatric- Mental Health Nurse Practitioner Final Exam Review | Complete Guide Questions and Verified Answers| 2023/ 2024!! |Chamberlain QUESTION Paroxetine warning Answer: this antidepressant has the highest risk of discontinuation syndrome d/t serotonin transporter inhibition and anticholinergic rebound. If treatment course has lasted 8 weeks, discontinue over 1-2 weeks. QUESTION serotonin syndrome Ans...

Final Exam: NR546/ NR 546 Psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner Final Exam | Questions and Verified Answers| Latest Update 2023/ 2024 |Chamberlain Q: What antidepressant has the longest half life? Answer: fluoxetine Q: What antidepressant also treats social anxiety and insomnia Answer: paroxetine Q: What antidepressant treats anxious depression smokers require increased do...

Final Exam: NR546/ NR 546 (Latest Update 2024/ 2025) Psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner Review| Complete Guide with Questions and Verified Answers| 100% Correct- Chamberlain Q: SSRI MOA inhibit 5HT reuptake first line of treatment for depression Q: SSRI s/e Answer: 7 S's of SSRIs 1.Stomach l dysfunction onin syndrome difficulties dal thoughts s (weight) Q: serotonin s/e Answer: head, red, fed head = decreased anxiety, impul...

Midterm Exam: NR546/ NR 546 Psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner | 2023/ 2024 Update| Questions and Verified Answers| New!! – Chamberlain Q: What diagnosis has a diagnosis of psychosis as a feature? Answer: mania depression cognitive disorders dementia Q: What are some positive symptoms? Answer: Hallucinations Delusions Thought disorder Hostility Excitability Q: What are some Negative symptoms? Answer: Affective flattening ...

Final Exam: NR546/ NR 546 (NEW Update 2024/ 2025) Psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner Review |Weeks 5-8 | Questions and Verified Answers| 100% Correct- Chamberlain QUESTION Tricyclic antidepressants (TCAs) Tricyclic antidepressants (TCAs) possess both SRI and NRI properties, but they also block other receptors, including α1-adrenergic, histamine-1, and muscarinic cholinergic receptors. TCAs are not used first-line because of the high incidence...